Clinical Trial Update: Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating memantine with or without raloxifene for cognitive preservation after brain irradiation; status shows NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• Evista (raloxifene)
• Namenda (memantine)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Brain Tumor | Phase 2 | Status: NOT_YET_RECRUITING